J O I N   O U R   M O N T H L Y   R E P O R T   &   U P D A T E   A L E R T S !  
.
   | Objective & Independent Equity Research
About Us Research Reports EquityNet in the News Affiliates Contact Us
.
Biostar Pharmaceuticals, Inc.
OTCBB: BSPM
Recommendation: STRONG BUY
12 Mo. Price Target: $9.13
FEATURED REPORT

Huifeng Bio-Pharmaceutical Technology, Inc
OTCBB: HFGB
Rating: Spec Buy
12 Mo. Price target is $2.37
FEATURED REPORT

SkyPeople Fruit Juice, Inc.
AMEX: SPU
Rating: BUY
12 mo. Price Target: $13.29
FEATURED REPORT

Welcome to EquityNet Research.  Here you will find a frequently updated list of the latest equity research, reviews and news you need to know when searching for stocks and company information. If you haven't done so already, take a minute to subscribe to our Monthly Report and Update Alerts!

EquityNet Research was formed in January 1999 to provide the investing public with professional, independent, objective research on under-followed public companies.


Is Analyst Coverage Necessary?
Take a look at these facts:

  • 70.9% in an Investopedia.com survey said that "a company that hires a legitimate fee-based research firm is making a positive statement about its investment potential."

  • According to a survey by Charles Schwab & Co. reported in the NY Times, an astonishing 78% of active stockholders now "value research from independent firms over analysis by Wall Street firms with financial ties to the companies they are rating..."

So why is independent research so important? It is much more than simply telling the story from an outside pair of eyes (though it does that). Independent research provides a benchmark by which potential investors can gauge a company's fair value, eliminating such extraneous factors as wars, political uncertainty, market-maker manipulation, etc. And perhaps most importantly, it is a statement by management to current shareholders and investors that, "We have the confidence in our business model to pay an independent analyst to perform a fair, accurate valuation on our stock. Not only do we not have anything to hide, we are sure the market will share our enthusiasm once all the facts are elicited."

BUYSIDE Magazine
March 2005

While some issuer-paid research firms keep their analysts on an independent contractor basis, Sherman Oaks, CA based EquityNet Research has revolved around the idea that the principals of the company think a stock is worth covering, it's worth them covering it on their own....

 

International Merchant Advisors to Complete Purchase of Medical Marijuana Company Organic Science, Inc. (PR Newswire)
Wed, 10 Mar 2010 21:52:00 Etc/GMT - International Merchant Advisors, Inc. www.imaiinc.com announced today that the company is preparing to complete the purchase of medical marijuana management and development company Organic Science, Inc.  Organic Science, Inc. is intended to become the primary operating subsidiary of IMAI in this business segment, and is focused on the implementation of Organic's  plans for acquisition and development of medically supervised Wellness Centers and medical marijuana clinics in selected markets throughout the USA.  International Merchant Advisors agreement to purchase Organic Science is subject to a valuation from an independent third party, and CEO Mel Roseman offered this update on its progress, "We believe that the valuation will meet or exceed our expectations, and anticipate closing on the purchase of Organic Science.

Semtech Announces Fourth Quarter of Fiscal Year 2010 Results (Business Wire)
Wed, 10 Mar 2010 21:30:00 Etc/GMT - CAMARILLO, Calif.----SEMTECH CORPORATION , a leading supplier of high performance analog and mixed-signal semiconductors, today reported un-audited financial results for the fourth quarter of fiscal year 2010 that ended January 31, 2010.

Wall St gains on economy bets; banks, techs lead (Reuters)
Wed, 10 Mar 2010 21:26:10 Etc/GMT - Bank and technology shares lifted Wall Street on Wednesday on hopes a revival in business demand will boost corporate profits.

Ducker Worldwide Announces Acquisition of Proprietary Strategy Planning System (PR Newswire)
Wed, 10 Mar 2010 21:25:00 Etc/GMT - Joanne Ulnick, Managing Partner, CEO of Ducker Worldwide today announced the acquisition of the proprietary StrategyPATHS® strategic decision-making system. StrategyPATHS® is a dynamic fact-based system of strategic decision-making that harnesses the power of collaboration.
     Copyright © 2010 EquityNet, Research. All rights reserved. Contact Us | Disclosure | Privacy Statement